RadarScope: JNJ — Analiza Fundamentala

Market Cap

$611.4B

P/E Ratio

29.3

Profit Margin

21.8%

ROE

26.3%

📈 Earnings Report — 2026-04

Ultimul trimestru raportat

EPS Actual

$2.7

▲ 9.8% QoQ▼ 2.5% YoY

EPS Estimat

$2.68

Beat by 0.7%

Revenue Actual

$24.06B

▼ 2.0% QoQ▲ 9.9% YoY

Revenue Estimat

$23.61B

Beat by 1.9%

Istoric Ultimele 4 Trimestre

2026-04

EPS Actual

$2.7

EPS Est.

$2.68

Revenue

$24.06B

Beat/Miss

Beat by 0.7%

2026-01

EPS Actual

$2.46

EPS Est.

$2.46

Revenue

$24.56B

Beat/Miss

Beat by 0.0%

2025-10

EPS Actual

$2.8

EPS Est.

$2.76

Revenue

$23.99B

Beat/Miss

Beat by 1.4%

2025-07

EPS Actual

$2.77

EPS Est.

$2.68

Revenue

$23.74B

Beat/Miss

Beat by 3.4%

Urmatorul Raport

Data

2026-07-15

EPS Estimat

$2.83

Revenue Estimat

$24.98B

💰 Dividende Recente

2026-05

$1.34

Yield: 227.65%

Plata: 2026-06

2026-02

$1.3

Yield: 211.14%

Plata: 2026-03

2025-11

$1.3

Yield: 248.71%

Plata: 2025-12

2025-08

$1.3

Yield: 287.84%

Plata: 2025-09

📊 Scoruri Companie

Crestere 7/10

Revenue & Profit Growth

Evaluare 5/10

P/E · P/B · P/S

Calitate 10/10

Marje · ROE · Datorii

Risc 3/10

Beta · Market Cap

📈 Date Financiare Istorice in miliarde USD

💰 Revenue

📊 Net Profit

💵 Cash Flow

Operating (albastru) · Free (violet)

🏦 Cash & Datorii

Cash (verde) · Long-term Debt (rosu)

💸 Operating Expenses

🤖 Analiza RadarScope AI

Analiza indisponibila temporar.

💡 Vezi datele de mai jos

🐂 BULL CASE

Date financiare solide

Pozitie competitiva puternica

🐻 BEAR CASE

Evaluare ridicata

Incertitudine macro

TINE Analiza manuala recomandata

📊 Metrici Fundamentale

P/E TTM29.3

P/B TTM7.65

P/S TTM6.34

EV/EBITDA—

Gross Margin69.1%

Operating Margin26.9%

Net Margin21.8%

ROE26.3%

ROA10.5%

Debt/Equity—

Current Ratio1.03

FCF Yield2.9%

Dividend Yield2.1%

Beta0.26

💰 Venituri & Profit (ultimele trimestre)

Trimestru	Revenue	Gross Profit	Net Income	EPS
2025-12	$94.2B	$68.6B	$26.8B	$11.03
2024-12	$88.8B	$61.4B	$14.1B	$5.84
2023-12	$85.2B	$58.6B	$35.2B	$13.88
2023-01	$80.0B	$55.4B	$17.9B	$6.83

🏢 Profil Companie

CEOJoaquin Duato

Angajati141700

IPO1962-01-02

Websitehttps://www.jnj.com...

52W High$259.88

52W Low$152.81

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories....

🎯 Score Breakdown

Calitate Companie (Q) 10/10

Risc Speculativ (R) 3/10

Scor AI RadarScope 50/100

VERDICT FINAL

TINE

Analiza manuala recomandata

🔒 Analiza completa disponibila cu cont SignalRadar